According to a new GlobaData report, almost half of all strategic alliances over the past 5 years (2019-2023), in the Asia Pacific region, centred on oligonucleotides.
Oligonucleotides accounted for 28 of the 59 strategic alliances in the report, which covered Australia, China, Japan and South Korea. The highest development stage for these deals was Phase 3.
The top deal seen, for antisense RNAi oligonucleotides, was a US$1.3bn deal between Hansoh Pharmaceutical Group from China and US-based Silence Therapeutics.
According to a pharma analyst at GlobalData, as the growing pipeline of RNA therapeutics brings new treatment approaches for unmet needs, we will see more partnerships for oligonucleotides.
“RNA therapies hold great promise for combating human diseases such as infectious diseases, cancer, neurodegeneration, metabolic disorders and rare genetic diseases.”
https://www.globaldata.com/media/ph...erapies-major-apac-countries-says-globaldata/
https://www.fiercebiotech.com/biote...-continues-charge-into-sirna-silence-r-d-pact
- Forums
- ASX - By Stock
- Ann: RP11 Drug Candidate Progressing to Mid-Stage Human Trials
According to a new GlobaData report, almost half of all...
Featured News
Add PYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.5¢ |
Change
0.005(5.00%) |
Mkt cap ! $489.9M |
Open | High | Low | Value | Volume |
10.5¢ | 11.0¢ | 9.8¢ | $820.7K | 8.043M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 1183096 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.0¢ | 1747310 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 1133096 | 0.100 |
1 | 30000 | 0.099 |
2 | 30400 | 0.098 |
2 | 3006289 | 0.097 |
11 | 552605 | 0.095 |
Price($) | Vol. | No. |
---|---|---|
0.110 | 1747310 | 8 |
0.115 | 540394 | 5 |
0.120 | 789122 | 6 |
0.125 | 671006 | 3 |
0.130 | 500000 | 1 |
Last trade - 16.10pm 21/05/2024 (20 minute delay) ? |
|
|||||
Last
10.0¢ |
  |
Change
0.005 ( 0.20 %) |
|||
Open | High | Low | Volume | ||
10.3¢ | 11.0¢ | 9.8¢ | 2924133 | ||
Last updated 15.59pm 21/05/2024 ? |
Featured News
PYC (ASX) Chart |
The Watchlist
AUQ
ALARA RESOURCES LIMITED
Stephen Gethin, Non-Executive Director & Chairman
Stephen Gethin
Non-Executive Director & Chairman
Previous Video
Next Video
SPONSORED BY The Market Online